吉利德78亿美元全面收购Arcellx公司获得BCMA-CAR T疗法

药企市值评估
Feb 27

春节以来的第一宗美股biotech并购大案由吉利德打响。近日,吉利德宣布以78亿美元估值全面收购其2022年就牵手合作的伙伴公司Arcellx,消息宣布当天Arcellx股价大涨近80%。这个收购价格相较于2月20日之前一个月平均股价溢价近70%。收购价格是每股115美元,外加CVR 5美元(行权条件是27/28/29三年累积销售额60亿美元)。Arcellx在成立10年出头了,以近80亿美元估值...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10